in Health

Top 5 Companies in Open-Angle Glaucoma Therapeutics Market. Read This!

Share to friends!

Open-angle glaucoma is a condition of the eye that leads to progressive atrophy of the optic nerve in the presence of an open angle. It is the most common form of glaucoma. 

Looking for more information on this market? Request a free sample report

beautiful-2315_640.jpg (640×426)

Many government and non-government organizations, as well as companies, are taking various initiatives to increase the awareness about glaucoma. For instance, the NIH runs a National Eye Health Education Program, under which the institutes publish various articles aimed at providing information about glaucoma, available treatments, and symptoms. Similarly, World Glaucoma Week is a joint initiative between the World Glaucoma Association and the World Glaucoma Patient Association. 

Along with awareness about glaucoma, the diagnosis of eye disorders, including glaucoma, also need a coordinated integrative effort, involving medical ophthalmologists, surgeons, and pathologists. A better interdisciplinary approach is needed to help tailoring the work-up, earlier diagnosis of co-existing diseases, and management of glaucoma patients. Such awareness programs and advances in diagnostic techniques in the field of ophthalmology will help in identifying glaucoma to detail and help ophthalmologists in providing the right treatment to the patients. Hence, growing awareness about glaucoma is expected to fuel the growth of the global open-angle glaucoma therapeutics market at a CAGR of 3.98% during the forecast period. 

Top Companies in Open-Angle Glaucoma Therapeutics Market

The global open-angle glaucoma therapeutics market is fragmented. To help clients improve their revenue share, the open-angle glaucoma therapeutics market research report provides an analysis of the market’s competitive landscape and offers information on the products offered by various companies. Key insights provided by the open-angle glaucoma therapeutics market analysis report will enable companies to make informed business decisions.

The report offers a detailed analysis of several leading open-angle glaucoma therapeutics companies, including:

  • Aerie Pharmaceuticals Inc.
  • Allergan Plc
  • Bausch Health Companies, Inc.
  • Novartis AG
  • Pfizer Inc.

Browse Full Report – http://bit.ly/35s5B9t

Share to friends!